본문 바로가기
KERD
논문KCI 등재

소아 결핵 진단에 있어서 결핵 특이항원자극 인터페론 감마 측정검사의 임상적 의의

Clinical Significance of Interferon γ Release Assay for Diagnosis of Tuberculosis in Children

1

조회

0

다운로드

4

인용

0

참고문헌

키워드

초록

목 적 : 본 연구는 소아에서 QuantiFERON-TB Gold (QTB) 검사의 임상적 유용성과 문제점을 평가하기 위해 시행되었다. 방 법: 2007년 1월부터 2009년 6월까지 본원에서TST와 QTB를 시행 받은 소아청소년 112명의 의무 기록을 후향적으로 조사하였다. 결 과: TST와 QTB의 양성률은 각각 59.8%, 15.2%였고, 두 검사의 일치도는 낮았다(κ=0.209). QTB의 민감도와 특이도는 각각 80.0%, 92.6%였다. QTB 양성율은 임상적 결핵군, 긴밀 접촉군, 일반 접촉군, 비접촉군에서 각각 80%, 14%, 0%, 2% 였으며, 판정보류의 빈도는 9.8%였다. QTB 추적 관찰이 시행된 환자 중, 초기QTB 양성이었던 6명 중 5명은 치료 종료 후 평균 2.2개월까지 양성이 지속되었다. 결 론:소아에서 QTB는 민감도가 낮고, 판정보류의빈도가 높다는 단점이 있으나, 특이도가 높은 장점이 있으므로, TST의 특이도가 낮은 점을 보완하여 결핵의 진단 및 치료 결정에 활용될 수 있을 것으로 생각된다.

Abstract

Purpose : The purpose of this study is to evaluate the usefulness and limitation of QuantiFERON-TB Gold (QTB) for diagnosis of latent tuberculosis in children. Methods : The medical records of 112 children who were tested by tuberculin skin test (TST) and QTB for detection of latent tuberculosis (TB) in Eulji General Hospital during the period from January 2007 to June 2009 were retrospectively reviewed. Results : Of the 112 participants, the clinical TB group included 15 (13.4%), the contact group included 43 (38.4%), and the non-contact group included 54 (48.2%). Positive rates of TST and QTB were 100% and 80% in the clinical TB group, 64%and 14% in the close contact group, 27% and 0% in the casual contact group, and 52% and 2% in the non-contact group,respectively. Sensitivity of QTB was 80.0% and specificity was 92.6%. Agreement between QTB and TST was poor (κ=0.209). We also confirmed that the positive rate of QTB increased as the age of the patient increased (P =0.011). A QTB indeterminate result was observed in 11 (9.8%) subjects. QTB was retested in 15 subjects. In 5 of the 6 subjects who had positive results initially, positive results persisted for a median 2.2 months after termination of treatment. Conclusion : Although QTB was associated with several problems, including low sensitivity and a high rate of indeterminate results, it had clinical importance due to its high specificity. We found good correlation with regard to exposure and QTB positivity, including that of young children under 5 years of age. However, clinical application of interferon-γ releasing assay for young children for diagnosis of active and latent tuberculosis will require additional prospective studies.

참고문헌 (39)

  1. World Health Organization, "Global tuberculosis control: surveilance, planning, financing", ~ (2002)
  2. 심태선, "국내에서 잠복결핵의 진단 및 치료", Tuberculosis and Respiratory Diseases, 57(2), pp.101~117 (2004), 대한결핵및호흡기학회
  3. Shin KC, "Report on the seventh national tuberculosis prevalence survey", The Korean Academy of Tuberculosis and Respiratory diseases, 85, pp.171~177 (1997)
  4. Marais BJ, "Childhood pulmonary tuberculosis: old wisdom and new challenges", Am J Respir Crit Care Med, 173, pp.1078~1090 (2006)
  5. Huebner RE, "The tuberculin skin test", Clin Infect Dis, 17, pp.968~975 (1993)
  6. Lighter J, "Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test", Pediatrics, 123, pp.30~37 (2009)
  7. Menzies D, "Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research", Ann Intern Med, 146, pp.340~354 (2007)
  8. Chee CB, "Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis- specific antigens", Am J Respir Crit Care Med, 175(3), pp.282~287 (2007)
  9. Ferrara G, "Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study", Lancet, 367, pp.1328~1334 (2006)
  10. Goletti D, "Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay", Clin Diagn Lab Immunol, 12, pp.1311~1316 (2005)
  11. Okada K, "Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children", Epidemiol Infect, 136, pp.1179~1187 (2008)
  12. Nakaoka H, "Risk for tuberculosis among children", Emerg Infect Dis, 12, pp.1383~1388 (2006)
  13. Liebeschuetz S, "Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study", Lancet, 364, pp.2196~2203 (2004)
  14. Haustein T, "The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status", Pediatr Infect Dis J, 28, pp.669~673 (2009)
  15. Lewinsohn DA, "Embracing interferon-gamma release assays for diagnosis of latent tuberculosis infection", Pediatr Infect Dis J, 28, pp.674~675 (2009)
  16. Powell DA, "Interferon gamma release assays in the evaluation of children with possible Mycobacterium tuberculosis infection: a view to caution", Pediatr Infect Dis J, 28, pp.676~677 (2009)
  17. Mazurek GH, "Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010", CDC Morbidity and Mortality weekly report, 59, pp.1~24 (2010)
  18. 성지연, "폐결핵 접촉력을 가진 소아에서 잠복 결핵 감염의 진단을 위한 결핵 특이항원 자극 인터페론-감마 측정의 유용성", 소아감염, 15(1), pp.51~57 (2008), 한국소아감염병학회
  19. 전진경, "소아 잠복 결핵 감염 진단에 있어서 투베르쿨린 피부반응 검사와 결핵 특이항원 자극 Interferon-γ 분비능 측정의 비교", Korean Journal of Pediatrics, 51(9), pp.971~976 (2008), 대한소아과학회
  20. 김영재, "소아에서 Interferon-γ 검사와 투베르쿨린 검사와의 비교", 대한소아알레르기및호흡기학회지, 20(1), pp.10~16 (2010), 대한 소아알레르기 호흡기학회
  21. 한유미, "Analysis of Patients with Positive Acid-fast Bacilli Culture and Negative T-SPOT.TB Results", The Korean Journal of Laboratory Medicine, 30(4), pp.414~419 (2010), 대한진단검사의학회
  22. 김보선, "경피용 BCG 백신의 PPD 1T U, 2T U 및 5T U 결핵 피부반응 검사에 대한 영향", 소아감염, 8(2), pp.175~180 (2001), 한국소아감염병학회
  23. Kim WS, "Conversion rates of tuberculin test according to BCG vaccination methods", J Korean Pediatr, 40, pp.489~496 (1997)
  24. Farhat M, "False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?", Int J Tuberc Lung Dis, 10, pp.1192~1204 (2006)
  25. American Academy of Pediatrics, "Committee on Infectious Diseases. Red book. report of the Committee on Infectious Diseases. 26th ed", pp.642~660 (2003), American Academy of Pediatrics
  26. Connell TG, "Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children", Thorax, 61, pp.616~620 (2006)
  27. Cehovin A, "Extended culture enhances sensitivity of a gamma interferon assay for latent Mycobacterium tuberculosis infection", Clin Vaccine Immunol, 14, pp.796~798 (2007)
  28. Leyten EM, "Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation", Clin Vaccine Immunol, 14, pp.880~885 (2007)
  29. In-Tube as useful tool, "Arch Pediatr", 2010, 77~85
  30. Bianchi L, "Interferon-gamma release assay improves the diagnosis of tuberculosis in children", Pediatr Infect Dis J, 28, pp.510~514 (2009)
  31. Kobashi Y, "Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice", Eur Respir J, 33, pp.812~815 (2009)
  32. Mazurek GH, "Guidelines for using the Quanti- FERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States", MMWR Recomm Rep, 54(15), pp.49~55 (2005)
  33. Ferrara G, "Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection", Am J Respir Crit Care Med, 172, pp.631~635 (2005)
  34. Luetkemeyer AF, "Comparison of an interferon- gamma release assay with tuberculin skin testing in HIV-infected individuals", Am J Respir Crit Care Med, 175, pp.737~742 (2007)
  35. Frenkel L, "Ontogeny of phytohemagglutinininduced gamma interferon by leukocytes of healthy infants and children: evidence for decreased production in infants younger than 2 months of age", J Pediatr, 111, pp.97~100 (1987)
  36. Miyawaki T, "Dissociated production of interleukin-2 and immune (gamma) interferon by phytohaemagglutinin stimulated lymphocytes in healthy infants", Clin Exp Immunol, 59, pp.505~511 (1985)
  37. Bosshard V, "Do results of the T-SPOT.TB interferon-gamma release assay change after treatment of tuberculosis?", Respir Med, 103, pp.30~34 (2009)
  38. Dheda K, "Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results", J Infect, 55, pp.169~173 (2007)
  39. Kobashi Y, "Long-term follow-up of the Quanti FERON TB-2G test for active tuberculosis disease", Intern Med, 47, pp.1957~1961 (2008)

관련 논문AI추천

이 간행물의 다른 논문 (13건)